885 publications
| Name | Date | Type | Actions |
|---|---|---|---|
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
Public releases | ||
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
Universal registration document 2023 XBRL version Universal Registration Document including the Annual Financial Report |
Reference document | ||
Universal registration document 2023 Universal Registration Document including the Annual Financial Report |
Reference document | ||
BALO : Notice of meeting Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions |
Shareholders´s Meeting | ||
Monthly information regarding the total number of voting rights – March 2024 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - March 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights |
Annual Report | ||
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
Public releases | ||
Monthly information regarding the total number of voting rights – February 2024 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights |